Literature DB >> 11053949

Association of transjugular intrahepatic portosystemic shunt with embolization in the treatment of bleeding duodenal varix refractory to sclerotherapy.

G Illuminati1, A Smail, D Azoulay, D Castaing, H Bismuth.   

Abstract

BACKGROUND: Bleeding from duodenal varices are often severe (mortality as high as 40%), and more difficult to sclerose than esophageal varices. We report a patient with a bleeding duodenal varix, refractory to sclerotherapy, successfully treated by the association of portosystemic shunt placement and varix embolization, via the same transjugular intrahepatic route.
METHODS: A 40-year-old Black male underwent emergency TIPS and duodenal varix embolization after failure of endoscopic sclerotherapy. The portosystemic pressure gradient droped from 16 to 9 mm Hg following TIPS. At 5 months from TIPS, the patient is well, with a patent shunt at Doppler ultrasound.
CONCLUSION: The present report of successful control of duodenal varix, actively bleeding and refractory to sclerotherapy, by means of combined TIPS and embolization, supports the role of TIPS and suggests that its association to embolization can be valuably considered in the difficult setting of portal hypertension with bleeding duodenal varices. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 11053949     DOI: 10.1159/000018885

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  3 in total

1.  Gastrointestinal bleeding from an obscure cause.

Authors:  Vikram Malladi
Journal:  MedGenMed       Date:  2005-03-23

2.  Bleeding duodenal varices successfully treated with TIPS.

Authors:  Jazon R Almeida; Leonardo Trevisan; Fábio Guerrazzi; Maria A Mesquita; José G Ferraz; Ciro G Montes; Néstor H Kisilwzky; Ademar Yamanaka; Elza C Soares
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

3.  Updates in the pathogenesis, diagnosis and management of ectopic varices.

Authors:  Ahmed Helmy; Khalid Al Kahtani; Mohamed Al Fadda
Journal:  Hepatol Int       Date:  2008-05-31       Impact factor: 6.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.